EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Characterization and Usefulness of Clot-Fibrinolysis Waveform Analysis in Critical Care Patients with Enhanced or Suppressed Fibrinolysis

Takumi Tsuchida iD, Mineji Hayakawa iD, Osamu Kumano iD

Thrombosis and Haemostasis · 01.01.2024 · 124 (01) · 040-048

DOI: 10.1055/a-2145-7139 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.01.2024. Verfasst von Takumi Tsuchida und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Acute and Critical Care Medicine, Department of Anesthesiology and Critical Care Medicine, Hokkaido University Faculty of Medicine, Sappo…. Hauptthemen laut MEDLINE: Fibrinolysis, Antifibrinolytic Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Recently, clot-fibrinolysis waveform analysis (CFWA), which is a coagulation and fibrinolysis global assay based on assessing the activated partial thromboplastin time with tissue-type plasminogen activator, was developed. This study aimed to investigate the characteristics of CFWA using plasma samples from patients in the critical care unit. Materials and Methods The fibrinolysis times using CFWA were measured in 298 plasma samples. These samples were divided into three groups based on the reference interval (RI) of fibrinolysis time using CFWA: shortened group, less than RI; within group, within RI; prolonged group, more than RI. The coagulation and fibrinolysis markers, including D-dimer, plasmin–α2 plasmin inhibitor complex (PIC), fibrin monomer complex (FMC), plasmin–α2 plasmin inhibitor (α2-PI), plasminogen (Plg), and fibrinogen (Fbg) were analyzed and compared among the three groups.

Results

The FMC level decreased in the order of shortened, within, and prolonged groups, and the decrease was statistically significant among all three group pairs. The opposite tendency was observed for Fbg and fibrinolysis-related markers of α2-PI and Plg, and significant differences were recognized in all pair comparisons except for between within and prolonged groups in Plg. The mean values of the fibrinolysis markers D-dimer and PIC in all three groups were higher than the cut-off values, and the PIC value differed significantly between the within and prolonged groups.

Conclusion

The fibrinolysis reaction was detected in all three groups, but the status differed. CFWA has the potential to reflect the fibrinolysis status in one global assay.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibrinolysisAntifibrinolytic AgentsHumansalpha-2-AntiplasminFibrinolysinFibrin Clot Lysis TimePlasminogenFibrinogenCritical Care

Substanzen

alpha-2-AntiplasminFibrinolysinAntifibrinolytic AgentsPlasminogenFibrinogen

Autor:innen und Institutionen

  • Division of Acute and Critical Care Medicine, Department of Anesthesiology and Critical Care Medicine, Hokkaido University Faculty of Medicine, Sapporo, Japan.
  • Sysmex Corporation, Kobe, Japan.
  • Health and Medical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Takamatsu, Japan.

ORCID-Profile: Takumi Tsuchida, Mineji Hayakawa, Osamu Kumano

Zitieren

APA

Tsuchida, T., Hayakawa, M., & Kumano, O. (2024). Characterization and Usefulness of Clot-Fibrinolysis Waveform Analysis in Critical Care Patients with Enhanced or Suppressed Fibrinolysis. Thrombosis and Haemostasis, 124(01), 040-048. https://doi.org/10.1055/a-2145-7139

Vancouver

Tsuchida T, Hayakawa M, Kumano O. Characterization and Usefulness of Clot-Fibrinolysis Waveform Analysis in Critical Care Patients with Enhanced or Suppressed Fibrinolysis. Thrombosis and Haemostasis. 2024;124(01):040-048. doi:10.1055/a-2145-7139

BibTeX
@article{Tsuchida2024,
  author = {Tsuchida, Takumi and Hayakawa, Mineji and Kumano, Osamu},
  title = {Characterization and Usefulness of Clot-Fibrinolysis Waveform Analysis in Critical Care Patients with Enhanced or Suppressed Fibrinolysis},
  journal = {Thrombosis and Haemostasis},
  year = {2024},
  volume = {124},
  number = {01},
  pages = {040--048},
  doi = {10.1055/a-2145-7139}
}
Kostenlos starten →